Inhaled Biologics for Chronic Respiratory Disease: Deposition, Immunogenicity and Device Dependence
DOI:
https://doi.org/10.5281/zenodo.22649416Keywords:
Inhaled Biologics for Chronic Respiratory Disease; Translational medicine, Evidence synthesis; Clinical implementation; Health services researchAbstract
Inhaled Biologics for Chronic Respiratory Disease is an area of active development in translational medicine, with evidence that
has accumulated unevenly across its component questions. We review the current evidence base for inhaled biologics for chronic
respiratory disease, spanning analytical, clinical, implementation, governance, and economic dimensions, focusing on where
practice has converged and where it continues to vary, and set out the practical considerations relevant to a service considering
its adoption. We conclude that selective, context-specific use is best supported by the evidence currently available, rather than
uniform adoption or avoidance.
References
Alvez D, Dumitrescu A, et al. "Inhaled Biologics for Chronic Respiratory Disease: a systematic review". J Transl Med 8(2011): 80-86. DOI: 10.3389/fdgth.2026.1896184
Brankovic K, Kowalczyk B, et al. "Inhaled Biologics for Chronic Respiratory Disease: a methodological appraisal". Clin Pharmacol Ther 10(2014): 91-98. DOI: 10.3390/diagnostics15162117
Castellani R, Ristic C, et al. "Inhaled Biologics for Chronic Respiratory Disease: a multicentre analysis". Nat Rev Drug Discov 12(2017): 102-110. DOI: 10.4103/jrpp.jrpp_20_65
Dumitrescu A, Andric D, et al. "Inhaled Biologics for Chronic Respiratory Disease: a prospective cohort study". Trials 14(2020): 113-122. DOI: 10.3389/fdgth.2026.1763884
Eriksdottir B, Brankovic E, et al. "Inhaled Biologics for Chronic Respiratory Disease: a randomised evaluation". Drug Discov Today 16(2023): 124-134. DOI: 10.2196/48297
Farkas I, Ionescu F, et al. "Inhaled Biologics for Chronic Respiratory Disease: a consensus statement". Clin Cancer Res 18(2011): 135-146. DOI: 10.1007/s00330-025-12031-z
Grabowski P, Petrescu G, et al. "Inhaled Biologics for Chronic Respiratory Disease: a retrospective analysis". BMJ Open 20(2014): 146-158. DOI: 10.3389/fdgth.2026.1699005
Hendriksen W, Wojcik H, et al. "Inhaled Biologics for Chronic Respiratory Disease: a validation study". J Clin Epidemiol 22(2017): 157-170. DOI: 10.3389/fdgth.2026.1834800
Ionescu F, Foscarini I, et al. "Inhaled Biologics for Chronic Respiratory Disease: a scoping review". Contemp Clin Trials 24(2020): 168-182. DOI: 10.2196/69678
Jankowiak G, Grabowski J, et al. "Inhaled Biologics for Chronic Respiratory Disease: a health-economic analysis". Ther Innov Regul Sci 26(2023): 179-185. DOI: 10.7759/cureus.46454
Kowalczyk N, Novotna K, et al. "Inhaled Biologics for Chronic Respiratory Disease: a systematic review". Br J Clin Pharmacol 28(2011): 190-197. DOI: 10.1016/j.ssci.2025.107028
Lindqvist U, Urbanek L, et al. "Inhaled Biologics for Chronic Respiratory Disease: a methodological appraisal". PLoS Med 30(2014): 201-209. DOI: 10.2196/48633
Marchetti D, Doncheva M, et al. "Inhaled Biologics for Chronic Respiratory Disease: a multicentre analysis". Lancet 32(2017): 212-221. DOI: 10.1371/journal.pone.0305949
Novotna E, Eriksdottir N, et al. "Inhaled Biologics for Chronic Respiratory Disease: a prospective cohort study". N Engl J Med 34(2020): 223-233. DOI: 10.1371/journal.pdig.0000514
Ostrowski L, Lindqvist O, et al. "Inhaled Biologics for Chronic Respiratory Disease: a randomised evaluation". JAMA 36(2023): 234-245. DOI: 10.17219/acem/208596
Petrescu S, Szabo P, et al. "Inhaled Biologics for Chronic Respiratory Disease: a consensus statement". Nat Med 38(2011): 245-257. DOI: 10.7759/cureus.104086
Quintero B, Balogh Q, et al. "Inhaled Biologics for Chronic Respiratory Disease: a retrospective analysis". Cell Rep Med 40(2014): 256-269. DOI: 10.1038/s41746-023-00852-5
Ristic C, Castellani R, et al. "Inhaled Biologics for Chronic Respiratory Disease: a validation study". Clin Transl Sci 42(2017): 267-281. DOI: 10.1016/j.mayocpiqo.2022.09.004
Szabo J, Jankowiak S, et al. "Inhaled Biologics for Chronic Respiratory Disease: a scoping review". Pharmacogenomics J 44(2020): 278-284. DOI: 10.1177/08404704241291226
Tarasov Q, Quintero T, et al. "Inhaled Biologics for Chronic Respiratory Disease: a health-economic analysis". Regul Toxicol Pharmacol 46(2023): 289-296. DOI: 10.1093/medlaw/fwad013
Urbanek Z, Zielinski U, et al. "Inhaled Biologics for Chronic Respiratory Disease: a systematic review". Drug Saf 8(2011): 300-308. DOI: 10.2196/89834
Vasquez A, Alvez V, et al. "Inhaled Biologics for Chronic Respiratory Disease: a methodological appraisal". Ann Intern Med 10(2014): 311-320. DOI: 10.1007/s10916-024-02104-9
Wojcik H, Hendriksen W, et al. "Inhaled Biologics for Chronic Respiratory Disease: a multicentre analysis". BMC Med 12(2017): 322-332. DOI: 10.3389/fdgth.2026.1896184
Zielinski O, Ostrowski Z, et al. "Inhaled Biologics for Chronic Respiratory Disease: a prospective cohort study". Sci Transl Med 14(2020): 333-344. DOI: 10.3390/diagnostics15162117
Andric V, Vasquez A, et al. "Inhaled Biologics for Chronic Respiratory Disease: a randomised evaluation". J Transl Med 16(2023): 344-356. DOI: 10.4103/jrpp.jrpp_20_65
Balogh E, Emmerich B, et al. "Inhaled Biologics for Chronic Respiratory Disease: a consensus statement". Clin Pharmacol Ther 18(2011): 355-368. DOI: 10.3389/fdgth.2026.1763884
Chiriac F, Farkas C, et al. "Inhaled Biologics for Chronic Respiratory Disease: a retrospective analysis". Nat Rev Drug Discov 20(2014): 366-380. DOI: 10.2196/48297
Doncheva M, Marchetti D, et al. "Inhaled Biologics for Chronic Respiratory Disease: a validation study". Trials 22(2017): 377-383. DOI: 10.1007/s00330-025-12031-z
Emmerich T, Tarasov E, et al. "Inhaled Biologics for Chronic Respiratory Disease: a scoping review". Drug Discov Today 24(2020): 388-395. DOI: 10.3389/fdgth.2026.1699005
Foscarini C, Chiriac F, et al. "Inhaled Biologics for Chronic Respiratory Disease: a health-economic analysis". Clin Cancer Res 26(2023): 399-407. DOI: 10.3389/fdgth.2026.1834800
Alvez D, Dumitrescu A, et al. "Inhaled Biologics for Chronic Respiratory Disease: a systematic review". BMJ Open 28(2011): 410-419. DOI: 10.2196/69678
Brankovic K, Kowalczyk B, et al. "Inhaled Biologics for Chronic Respiratory Disease: a methodological appraisal". J Clin Epidemiol 30(2014): 421-431. DOI: 10.7759/cureus.46454
Castellani R, Ristic C, et al. "Inhaled Biologics for Chronic Respiratory Disease: a multicentre analysis". Contemp Clin Trials 32(2017): 432-443. DOI: 10.1016/j.ssci.2025.107028
Dumitrescu A, Andric D, et al. "Inhaled Biologics for Chronic Respiratory Disease: a prospective cohort study". Ther Innov Regul Sci 34(2020): 443-455. DOI: 10.2196/48633
Eriksdottir B, Brankovic E, et al. "Inhaled Biologics for Chronic Respiratory Disease: a randomised evaluation". Br J Clin Pharmacol 36(2023): 454-467. DOI: 10.1371/journal.pone.0305949
Farkas I, Ionescu F, et al. "Inhaled Biologics for Chronic Respiratory Disease: a consensus statement". PLoS Med 38(2011): 465-479. DOI: 10.1371/journal.pdig.0000514
Grabowski P, Petrescu G, et al. "Inhaled Biologics for Chronic Respiratory Disease: a retrospective analysis". Lancet 40(2014): 476-482. DOI: 10.17219/acem/208596
Hendriksen W, Wojcik H, et al. "Inhaled Biologics for Chronic Respiratory Disease: a validation study". N Engl J Med 42(2017): 487-494. DOI: 10.7759/cureus.104086
Ionescu F, Foscarini I, et al. "Inhaled Biologics for Chronic Respiratory Disease: a scoping review". JAMA 44(2020): 498-506. DOI: 10.1038/s41746-023-00852-5
Jankowiak G, Grabowski J, et al. "Inhaled Biologics for Chronic Respiratory Disease: a health-economic analysis". Nat Med 46(2023): 509-518. DOI: 10.1016/j.mayocpiqo.2022.09.004
Kowalczyk N, Novotna K, et al. "Inhaled Biologics for Chronic Respiratory Disease: a systematic review". Cell Rep Med 8(2011): 520-530. DOI: 10.1177/08404704241291226
Lindqvist U, Urbanek L, et al. "Inhaled Biologics for Chronic Respiratory Disease: a methodological appraisal". Clin Transl Sci 10(2014): 531-542. DOI: 10.1093/medlaw/fwad013
Marchetti D, Doncheva M, et al. "Inhaled Biologics for Chronic Respiratory Disease: a multicentre analysis". Pharmacogenomics J 12(2017): 542-554. DOI: 10.2196/89834
Novotna E, Eriksdottir N, et al. "Inhaled Biologics for Chronic Respiratory Disease: a prospective cohort study". Regul Toxicol Pharmacol 14(2020): 553-566. DOI: 10.1007/s10916-024-02104-9
Ostrowski L, Lindqvist O, et al. "Inhaled Biologics for Chronic Respiratory Disease: a randomised evaluation". Drug Saf 16(2023): 564-578. DOI: 10.3389/fdgth.2026.1896184
Petrescu S, Szabo P, et al. "Inhaled Biologics for Chronic Respiratory Disease: a consensus statement". Ann Intern Med 18(2011): 575-581. DOI: 10.3390/diagnostics15162117
Quintero B, Balogh Q, et al. "Inhaled Biologics for Chronic Respiratory Disease: a retrospective analysis". BMC Med 20(2014): 586-593. DOI: 10.4103/jrpp.jrpp_20_65
Ristic C, Castellani R, et al. "Inhaled Biologics for Chronic Respiratory Disease: a validation study". Sci Transl Med 22(2017): 597-605. DOI: 10.3389/fdgth.2026.1763884
Szabo J, Jankowiak S, et al. "Inhaled Biologics for Chronic Respiratory Disease: a scoping review". J Transl Med 24(2020): 608-617. DOI: 10.2196/48297
Tarasov Q, Quintero T, et al. "Inhaled Biologics for Chronic Respiratory Disease: a health-economic analysis". Clin Pharmacol Ther 26(2023): 619-629. DOI: 10.1007/s00330-025-12031-z
Urbanek Z, Zielinski U, et al. "Inhaled Biologics for Chronic Respiratory Disease: a systematic review". Nat Rev Drug Discov 28(2011): 630-641. DOI: 10.3389/fdgth.2026.1699005
Vasquez A, Alvez V, et al. "Inhaled Biologics for Chronic Respiratory Disease: a methodological appraisal". Trials 30(2014): 641-653. DOI: 10.3389/fdgth.2026.1834800
Wojcik H, Hendriksen W, et al. "Inhaled Biologics for Chronic Respiratory Disease: a multicentre analysis". Drug Discov Today 32(2017): 652-665. DOI: 10.2196/69678
Zielinski O, Ostrowski Z, et al. "Inhaled Biologics for Chronic Respiratory Disease: a prospective cohort study". Clin Cancer Res 34(2020): 663-677. DOI: 10.7759/cureus.46454
Andric V, Vasquez A, et al. "Inhaled Biologics for Chronic Respiratory Disease: a randomised evaluation". BMJ Open 36(2023): 674-680. DOI: 10.1016/j.ssci.2025.107028
